Diltiazem cream - Assembly Biosciences/SLA Pharma

Drug Profile

Diltiazem cream - Assembly Biosciences/SLA Pharma

Alternative Names: 2% Diltiazem cream - SLA Pharma; Anoheal; Diltiazem hydrochloride 2% cream; Diltiazem hydrochloride 4% cream; SLV-324; VEN 307

Latest Information Update: 29 Jul 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SLA Pharma
  • Developer Assembly Biosciences
  • Class Antihypertensives; Benzazepines; Ischaemic heart disorder therapies; Small molecules
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Fissure in ano

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 29 Jul 2014 Discontinued - Phase-III for Fissure in ano in Germany (Rectal)
  • 25 Jul 2014 Discontinued - Phase-III for Fissure in ano in Bulgaria (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top